| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |